# Obatala Sciences

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/obatala-sciences

- Industry: Biotechnology
- Headquarters: New Orleans, US
- Website: www.obatalasciences.com
- Total disclosed funding: $3M
- Latest round: Series A (Oct 13, 2022)
- Investors on record: 5

## About

Obatala Sciences Inc is focused on developing and manufacturing human-derived biomaterials, including hydrogels and functional models for pre-clinical drug development, aiming to enhance research and therapeutic strategies.Founded in 2017, Obatala Sciences Inc operates out of New Orleans, US, specializing in the development of human-derived biomaterials. The company was founded by Jeffrey Gimble. In 2022, Obatala secured USD 3.000 mn in Series A funding, attracting investors such as Benson Capital Partners and Ochsner Clinic Foundation Retirement Plan.Obatala Sciences specializes in the development and manufacturing of human-derived biomaterials, focusing on hydrogels, stem cells, and functional Fat-on-a-Chip models for pre-clinical drug development. Their flagship product, ObaGel®, mimics the in vivo environment, facilitating advanced research into metabolic diseases. The ObaCell® technology enables researchers to use adipose tissue models that incorporate human diversity, serving clients including pharmaceutical companies and academic institutions across North America and Europe.Obatala Sciences generates revenue through direct sales of specialized products and services to research institutions and pharmaceutical companies, including ObaGel® and ObaCell® kits. Their business model includes direct sales and consulting services, tailored to meet specific research applications, fostering long-term partnerships with clients.In October 2022, Obatala Sciences Inc. raised USD 3.000 mn in Series A funding, co-led by new investors être Venture Capital and Ochsner Clinic Foundation Retirement Plan. The company plans to utilize this funding to expand its platform capabilities and market reach, supporting its next phase of growth.

## Funding rounds

- Series A, Oct 13, 2022, $3M — The Hackett Group, Inc., Ochsner Clinic Foundation Retirement Plan, Elevate Capital, Benson Capital Partners, etre Venture Capital

## Investors

- The Hackett Group, Inc. — Series A
- Ochsner Clinic Foundation Retirement Plan — Series A
- Elevate Capital (https://capitalatlas.ai/funds/elevate-capital) — Series A
- Benson Capital Partners (https://capitalatlas.ai/funds/benson-capital-partners) — Series A
- etre Venture Capital (https://capitalatlas.ai/funds/etre-venture-capital) — Series A